These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38857643)

  • 1. Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive Study.
    Lin J; Bu F; Wu D; Jiang P; He Q; Yang D; Zhu X; Wang Y; Xiang X
    J Pharm Sci; 2024 Sep; 113(9):2861-2870. PubMed ID: 38857643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Tissue Distribution of Pilocarpine After Application to Eyelid Skin of Rats.
    See GL; Sagesaka A; Todo H; Wierzba K; Sugibayashi K
    J Pharm Sci; 2019 Sep; 108(9):2942-2948. PubMed ID: 31002809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues.
    See GL; Sagesaka A; Sugasawa S; Todo H; Sugibayashi K
    Int J Pharm; 2017 Nov; 533(1):198-205. PubMed ID: 28965801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits.
    Bussing D; K Shah D
    J Pharmacokinet Pharmacodyn; 2020 Dec; 47(6):597-612. PubMed ID: 32876799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative distribution of pilocarpine in ocular tissues of the rabbit during administration by eyedrop or by membrane-controlled delivery systems.
    Sendelbeck L; Moore D; Urquhart J
    Am J Ophthalmol; 1975 Aug; 80(2):274-83. PubMed ID: 1155567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.
    Le Merdy M; AlQaraghuli F; Tan ML; Walenga R; Babiskin A; Zhao L; Lukacova V
    Pharm Res; 2023 Feb; 40(2):431-447. PubMed ID: 36151444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits.
    Miller SC; Himmelstein KJ; Patton TF
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):653-77. PubMed ID: 7341754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
    Deng F; Ranta VP; Kidron H; Urtti A
    Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits.
    Weiss SL; Kramer WG
    J Ocul Pharmacol Ther; 2019 Sep; 35(7):395-402. PubMed ID: 31355703
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged Distribution of Tranilast in the Eyes after Topical Application onto Eyelid Skin.
    See GL; Arce F; Itakura S; Todo H; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2020; 68(8):779-783. PubMed ID: 32741920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine.
    Camber O; Edman P
    Curr Eye Res; 1989 Jun; 8(6):563-7. PubMed ID: 2743795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits.
    Naveh N; Muchtar S; Benita S
    J Ocul Pharmacol; 1994; 10(3):509-20. PubMed ID: 7836859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development.
    Le Merdy M; Tan ML; Babiskin A; Zhao L
    AAPS J; 2020 Jan; 22(2):26. PubMed ID: 31907674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.
    Le Merdy M; Spires J; Lukacova V; Tan ML; Babiskin A; Xu X; Zhao L; Bolger MB
    Pharm Res; 2020 Nov; 37(12):245. PubMed ID: 33215336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of topical prazosin and pilocarpine on uveoscleral outflow in rabbit eyes.
    Wang J; Song Y; Ren B; Sun N; Yu Y; Hu H
    Yan Ke Xue Bao; 2003 Sep; 19(3):191-4. PubMed ID: 14574980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies.
    Naware S; Bussing D; Shah DK
    J Pharmacokinet Pharmacodyn; 2023 Aug; ():. PubMed ID: 37558929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits].
    Xu Y; Chen Z; Song J; Zhang J; Xie L
    Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):446-8. PubMed ID: 11835858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A; Prusakiewicz JJ; Oswald J; Spencer E; Lou Z; Cohen ML; Rashidzadeh H; Josiah S
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
    Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.